Edition:
United States

Advanced Oncotherapy PLC (AVO.L)

AVO.L on London Stock Exchange

20.50GBp
25 Sep 2017
Change (% chg)

0.50 (+2.50%)
Prev Close
20.00
Open
20.00
Day's High
--
Day's Low
--
Volume
478,125
Avg. Vol
316,773
52-wk High
120.00
52-wk Low
9.52

Chart for

About

Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device and management of healthcare related property.... (more)
No analyst recommendations are available for .

Overall

Beta: 0.13
Market Cap(Mil.): £16.19
Shares Outstanding(Mil.): 80.94
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 175.74 16.08
EPS (TTM): -- -- --
ROI: -- 9.48 14.60
ROE: -- 14.73 14.03

BRIEF-Advanced Oncotherapy updates on conversion of convertible loan notes

* Announces Bracknor Investment advised company they will convert portion of convertible loan notes to shares of 25p each Source text for Eikon: Further company coverage:

Jun 21 2017

Earnings vs. Estimates